This research was aimed to comprehensively investigate the expression levels, diagnostic and prognostic implications, and the relationship with immune infiltration of G2 and S phase‐expressed‐1 (GTSE1) across 33 tumor types, including lung adenocarcinoma (LUAD), through gene expression profiling. This evidence concerns the gene GTSE1 and lung adenocarcinoma.